Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Ina v. CV Sciences, Inc. et al
Case Number:
2:18-cv-01602
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
Companies
Sectors & Industries:
-
February 01, 2022
CBD Co. Inks $712K Deal To End Investors' Securities Suit
Investors who accused CBD company CV Sciences Inc. of misleading them about a rejected patent application have reached a tentative $712,500 settlement with the business to end their claims, Nevada federal court documents show.
-
July 15, 2021
Sanctions Objections Overruled In CBD Co. Securities Suit
A Nevada federal judge on Wednesday overruled objections filed by CBD company CV Sciences Inc. and its former executives, after a magistrate judge partially granted a sanctions motion in a class action alleging the company misled investors about a rejected patent application.
-
March 05, 2021
CBD Co. Execs Can't Rewrite Admissions, Investor Says
Executives of a CBD company shouldn't be allowed to take back admissions they already made, an investor in the company told a Nevada federal judge in regards to his case against them.
-
January 11, 2021
Investor Slams Sanctions Objection In CBD Co. Securities Suit
The lead plaintiff in a securities class action against a CBD company that allegedly misled investors about a rejected patent application has pushed back against objections filed by the company and its former executives after a magistrate judge hit them with sanctions.
-
October 06, 2020
Investor Wants Attys Sanctioned In CBD Co. Securities Suit
Attorneys for two former executives of a CBD company embroiled in a securities class action deserve sanctions for concealing evidence, stonewalling discovery requests and raising frivolous objections, the lead plaintiff in the case has told a Nevada federal court.
-
December 11, 2019
CBD Co. Can't Escape Securities Class Action
A Nevada federal judge has refused to dismiss a securities class action against a CBD company that allegedly misled investors about a rejected patent application that, when publicized, caused a stock drop of over 50%.